Abstract
The presence of human leukocyte antigen (HLA) antibodies has been associated with cardiac allograft vasculopathy (CAV) after heart transplant (HT). The virtual crossmatch (VXM) involves quantification of HT candidate HLA specific antibodies and the subsequent avoidance of corresponding donor antigens. The purpose of our study was to compare the incidence of CAV at one year post HT between patients (pts) with positive panel reactive antibodies (PRA) who underwent VXM (VXM group) versus pts with 0% PRA, who did not undergo VXM (No VXM group).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
